SPYRE THERAPEUTICS, INC. Accrued Liabilities and Other Liabilities
SPYRE THERAPEUTICS, INC. (SYRE) had Accrued Liabilities and Other Liabilities of $26.18 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Payables and Accruals
us-gaap:AccruedLiabilitiesAndOtherLiabilities · last filed 2026-08-04
- 2026-06-30: Accrued Liabilities and Other Liabilities $26.18M.
- 2026-03-31: Accrued Liabilities and Other Liabilities $29.16M.
- 2025-12-31: Accrued Liabilities and Other Liabilities $26.95M.
- 2025-09-30: Accrued Liabilities and Other Liabilities $23.83M.
| Period end | Accrued Liabilities and Other Liabilities |
|---|---|
| 2026-06-30 | $26.18M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $29.16M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $26.95M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $23.83M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $19.42M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $21.63M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $27.71M 10-K · filed 2026-02-19 |
| 2024-09-30 | $13.15M 10-Q/A · filed 2024-11-18 |
| 2024-06-30 | $5.68M 10-Q/A · filed 2024-11-18 |
| 2024-03-31 | $21.59M 10-Q/A · filed 2024-11-18 |
| 2023-12-31 | $13.11M 10-K · filed 2025-02-27 |
| 2023-09-30 | $15.86M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $28.43M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $9.66M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $12.84M 10-K/A · filed 2024-11-18 |
| 2022-09-30 | $12.41M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $13.14M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $10.79M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $14.03M 10-K · filed 2023-03-02 |
| 2021-09-30 | $13.36M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $12.44M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $10.95M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $13.87M 10-K · filed 2022-03-08 |
| 2020-09-30 | $11.71M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $11.51M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $13.23M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $14.85M 10-K · filed 2021-03-18 |
| 2019-09-30 | $12.68M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $9.97M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $8.27M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $9.58M 10-K · filed 2020-02-24 |
| 2018-09-30 | $6.44M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $5.22M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $5.00M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $5.22M 10-K · filed 2019-03-07 |
| 2017-09-30 | $4.21M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $3.71M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $3.64M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $3.73M 10-K · filed 2018-03-13 |
| 2016-09-30 | $3.13M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $3.01M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $3.31M 10-Q · filed 2016-05-19 |
| 2015-12-31 | $2.35M 10-K · filed 2017-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |